QA: Skye Bioscience Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516551_2017_Skye_Bioscience_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001516551, Skye Bioscience Inc

  xvar xval
0 AssetsCurrent 279,489
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 9,584
3 remainder_Assets 34,290
4 LiabilitiesCurrent 661,958
5 LiabilitiesNoncurrent 1,112,308
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,406,704
9 ResearchAndDevelopmentExpense 2,753,774
10 remainder_Expenses -5,646,836
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 323,363
1 Liabilities 1,774,266
2 Expenses 513,642
3 Revenues 0
4 StockholdersEquity -1,450,903
5 NetIncome -513,642
6 ComprehensiveNetIncome -513,642
7 BaseVar 1,305,636
8 EconomicCapitalRatiobeforeLimitedLiability -3.51
9 EconomicCapitalRatio 0.528

Edgar->Model Mapping

Feature Distribution

Change over Time